CHWY vs SUPN · P/E 45, rev $12.60B vs rev $426.8M
Chewy Inc (CHWY) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
Chewy Inc (CHWY) is a internet retail company listed on US.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CHWY revenue for 2026-02-01 was $12.60B. Net income was $222.8M. Revenue was up 6.2% from 2025-02-02 to 2026-02-01. CHWY currently screens at market cap $16.92B and trailing P/E 45.0.
Latest reported SUPN revenue for 2026-06-30 was $426.8M. Net income was -$60.7M. SUPN currently screens at market cap $2.53B.
CHWY currently screens at market cap $16.92B and trailing P/E 45.0. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the CHWY and SUPN stock pages for the full models.
Not investment advice.